Cargando…

Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922

The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Toshiaki, Tojo, Naomi, Ohnishi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822487/
https://www.ncbi.nlm.nih.gov/pubmed/35154433
http://dx.doi.org/10.3892/ol.2022.13222
_version_ 1784646617554485248
author Tani, Toshiaki
Tojo, Naomi
Ohnishi, Ken
author_facet Tani, Toshiaki
Tojo, Naomi
Ohnishi, Ken
author_sort Tani, Toshiaki
collection PubMed
description The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been reported to exhibit cancer stem cell-like properties. The present study used CD133-positive cells from a glioblastoma cell line (T98G) as cancer stem cell-like cells. CD133-positive and negative cells were sorted from T98G spheroids using fluorescence-activated cell sorting and used for colony formation assay. Colony formation assay results indicated that NVP-AUY922 enhanced radiosensitivity more strongly in CD133-positive cells compared with CD133-negative cells. This result showed that NVP-AUY922 was a preferential radiosensitization candidate targeting glioblastoma cancer stem cells. The mechanisms underlying radiosensitization by NVP-AUY922 are discussed in relation to the properties of cancer stem cells. Overall, HIF-1α inhibition by NVP-AUY922 may induce higher sensitization of cancer stem cells to radiation.
format Online
Article
Text
id pubmed-8822487
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-88224872022-02-10 Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 Tani, Toshiaki Tojo, Naomi Ohnishi, Ken Oncol Lett Articles The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been reported to exhibit cancer stem cell-like properties. The present study used CD133-positive cells from a glioblastoma cell line (T98G) as cancer stem cell-like cells. CD133-positive and negative cells were sorted from T98G spheroids using fluorescence-activated cell sorting and used for colony formation assay. Colony formation assay results indicated that NVP-AUY922 enhanced radiosensitivity more strongly in CD133-positive cells compared with CD133-negative cells. This result showed that NVP-AUY922 was a preferential radiosensitization candidate targeting glioblastoma cancer stem cells. The mechanisms underlying radiosensitization by NVP-AUY922 are discussed in relation to the properties of cancer stem cells. Overall, HIF-1α inhibition by NVP-AUY922 may induce higher sensitization of cancer stem cells to radiation. D.A. Spandidos 2022-03 2022-01-31 /pmc/articles/PMC8822487/ /pubmed/35154433 http://dx.doi.org/10.3892/ol.2022.13222 Text en Copyright: © Tani et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Tani, Toshiaki
Tojo, Naomi
Ohnishi, Ken
Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title_full Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title_fullStr Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title_full_unstemmed Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title_short Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
title_sort preferential radiosensitization to glioblastoma cancer stem cell-like cells by a hsp90 inhibitor, n-vinylpyrrolidone-auy922
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822487/
https://www.ncbi.nlm.nih.gov/pubmed/35154433
http://dx.doi.org/10.3892/ol.2022.13222
work_keys_str_mv AT tanitoshiaki preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922
AT tojonaomi preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922
AT ohnishiken preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922